Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Gene Therapy Market from 2024 to 2025?#_x000D_

Over recent years, the gene therapy market has experienced tremendous expansion. It is expected to elevate from a value of $12.52 billion in 2024 to $16.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.7%. The swell in growth during the historical period can be ascribed to factors such as heightened pharmaceutical R&D spending, an increase in public-private collaborations, governmental funding, and a surge in instances of spinal muscular atrophy._x000D_

_x000D_

#What Is the Projected Market Size of the Gene Therapy Market?#_x000D_

Rapid expansion is anticipated for the gene therapy market in the coming years, with projections showing a leap to $31.48 billion by 2029, characterized by a compound annual growth rate (CAGR) of 17.8%. Factors contributing to this predicted growth during the forecast period include a surge in cancer cases, an aging demographic, increased pharmaceutical R&D investment and a stronger emphasis on gene therapy. Key trends expected to emerge during the forecast period include acquiring regulatory permissions to improve business functions, fortifying business activities via strategic alliances and partnerships, growing business capabilities via strategic takeovers, and bolstering operational competencies through business expansions._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Gene Therapy Market Outlook?#_x000D_

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi_x000D_

_x000D_

#What Is Fueling Growth in the Gene Therapy Market?#_x000D_

The escalating incidence of cancer and other specific diseases is necessitating compelling solutions, resulting in a surge in the gene therapy market’s growth. A global increase in cancer cases can be expected to stimulate the expansion of this market throughout the upcoming years. For instance, the American Cancer Society revealed in January 2022 that the US is likely to see about 1.9 million new cancer diagnoses and approximately 609,360 deaths related to cancer, translating to around 1,670 deaths daily. The four most prevalent types of cancer globally, lung, prostate, bowel, and female breast cancer, represent 43 percent of all new cancer instances. Consequently, the global surge in the rate of cancer incidences is predicted to spark an increased demand for the gene therapy market in the near future. Known as one of the most efficient treatments in oncology, gene therapy introduces new genes within a cancerous cell or its surrounding tissue, effectively inducing cell death or inhibiting the cancer growth._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp_x000D_

_x000D_

#Which Gene Therapy Market Segments Are Growing the Fastest?#_x000D_

The gene therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy_x000D_

2) By Vector: Viral Vector, Non-Viral Vector_x000D_

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders_x000D_

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations_x000D_

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Gene Therapy Market?#_x000D_

Machine learning and artificial intelligence are steadily becoming more prevalent in the gene therapy market. AI emulates human intelligence in machines, which are configured to demonstrate their inherent intelligence. Machine learning, a component of AI, enables companies in the gene therapy market to thoroughly review all pertinent data, obtain insights into tumor and immune cell interactions, and provide a more precise assessment of tissue samples, a common source of conflict among different evaluators. For example, Form Bio, a US-based software company specializing in life sciences, introduced FORMsightAI, a novel AI-powered solution set for forecasting and improving cell and gene therapy constructs manufacturing outputs, in May 2023. This comprehensive solution merges state-of-the-art, flexible AI models with Form Bio’s foundational platform and a competent team of computational life sciences professionals with expertise in biology, bioinformatics, and data science. FORMsightAI tackles common challenges encountered by cell and gene therapy developers like construct truncations and manufacturing contaminations, which are primary reasons for unacceptable low manufacturing yields, delayed market timelines, and therapeutic safety issues._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Gene Therapy Market?#_x000D_

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the gene therapy market, and how is it changing globally?_x000D_

2. Who are the major companies in the gene therapy market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the gene therapy market right now?_x000D_

4. Which products or customer segments are growing the most in the gene therapy market?_x000D_

5. What factors are helping or slowing down the growth of the gene therapy market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model